Guardant Health, Inc. (GH)
Largest Insider Buys in Sector
GH Stock Price History Chart
GH Stock Performance
About Guardant Health, Inc.
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and …
Insider Activity of Guardant Health, Inc.
Over the last 12 months, insiders at Guardant Health, Inc. have bought $38,963 and sold $629,771 worth of Guardant Health, Inc. stock.
On average, over the past 5 years, insiders at Guardant Health, Inc. have bought $8.18M and sold $426.48M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Kalia Kumud (Chief Information Officer) — $38,963.
The last purchase of 2,187 shares for transaction amount of $38,963 was made by Kalia Kumud (Chief Information Officer) on 2024‑03‑18.
List of Insider Buy and Sell Transactions, Guardant Health, Inc.
| 2024-12-18 | Sale | director | 116 0.0001% | $34.85 | $4,043 | -9.10% | ||
| 2024-12-13 | Sale | director | 2,320 0.0019% | $35.00 | $81,200 | +0.23% | ||
| 2024-12-02 | Sale | director | 100 <0.0001% | $35.90 | $3,590 | +0.34% | ||
| 2024-11-18 | Sale | Chief Information Officer | 7,000 0.0057% | $29.25 | $204,722 | +4.49% | ||
| 2024-11-13 | Sale | director | 2,896 0.0022% | $29.90 | $86,595 | +11.99% | ||
| 2024-11-12 | Sale | director | 8,318 0.0067% | $29.45 | $244,930 | +18.57% | ||
| 2024-06-04 | Sale | director | 100 <0.0001% | $27.87 | $2,787 | +3.88% | ||
| 2024-03-18 | Chief Information Officer | 2,187 0.0018% | $17.82 | $38,963 | +46.16% | |||
| 2024-03-04 | Sale | director | 100 <0.0001% | $19.05 | $1,905 | +32.61% | ||
| 2023-12-04 | Sale | director | 100 <0.0001% | $26.34 | $2,634 | -11.50% | ||
| 2023-12-01 | Sale | Chief Information Officer | 5,800 0.0049% | $26.37 | $152,954 | -9.02% | ||
| 2023-09-12 | Sale | Chief Information Officer | 2,125 0.0018% | $32.59 | $69,254 | -21.71% | ||
| 2023-09-05 | Sale | director | 100 <0.0001% | $35.01 | $3,501 | -27.58% | ||
| 2023-06-15 | Sale | director | 2,766 0.0027% | $37.55 | $103,863 | -31.14% | ||
| 2023-06-09 | Chief Information Officer | 2,981 0.0029% | $32.71 | $97,498 | -20.79% | |||
| 2023-03-15 | Co-Chief Executive Officer | 8,600 0.0082% | $26.15 | $224,928 | -0.41% | |||
| 2023-03-14 | Co-Chief Executive Officer | 84,452 0.0813% | $26.33 | $2.22M | 0.00% | |||
| 2023-03-14 | Co-Chief Executive Officer | 12,750 0.0123% | $26.40 | $336,564 | 0.00% | |||
| 2023-03-13 | Co-Chief Executive Officer | 60,000 0.0581% | $25.66 | $1.54M | +3.21% | |||
| 2023-03-03 | Sale | Chief Information Officer | 6,500 0.0063% | $31.92 | $207,466 | -16.18% |
Insider Historical Profitability
| Kalia Kumud | Chief Information Officer | 17744 0.0144% | $31.67 | 2 | 6 | <0.0001% |
| SOFTBANK VISION FUND (AIV M1) L.P. | 10 percent owner | 27850460 22.5409% | $31.67 | 1 | 0 | +5.91% |
| Eltoukhy Helmy | Co-Chief Executive Officer | 2049238 1.6586% | $31.67 | 4 | 37 | <0.0001% |
| Talasaz AmirAli | Co-Chief Executive Officer | 1902345 1.5397% | $31.67 | 4 | 48 | <0.0001% |
Institutional Investor Ownership
| The Vanguard Group | $235.93M | 9.35 | 11.44M | +2.74% | +$6.3M | <0.01 | |
| BlackRock | $227.22M | 9 | 11.01M | +1.68% | +$3.76M | 0.01 | |
| Baillie Gifford Co | $128.57M | 5.09 | 6.23M | +0.86% | +$1.1M | 0.1 | |
| Deep Track Capital Lp | $123.78M | 4.9 | 6M | +20% | +$20.63M | 0.57 | |
| Cadian Capital Management LP | $119.51M | 4.73 | 5.79M | +715.88% | +$104.86M | 4.25 |